We have previously shown the involvement of the receptor tyrosine kinase MET and its ligand HGF (also known as scatter factor, HGF/SF) in tumor-bone interaction contributing to human breast cancer bone metastases [9]. This evidence concerns the gene MET and breast carcinoma.